Abstract:The burden of sepsis as a leading cause of global morbidity and mortality is well documented. Sepsis results in high resource utilization and increasing healthcare costs often leaving survivors with life-long disabilities. Numerous novel treatment modalities have often failed in clinical trials in part, because of the heterogeneity of the disease process. These failures have highlighted the critical role that sepsis prevention and early detection play in treatment. Early recognition and prompt initiation of treatment offers the opportunity to intervene before multiple organ system failure commences. Research in the adult patient realm has made great strides with consensus definitions and work to identify biomarkers. In other areas of adult-focused research, emerging technologies have allowed for targeted therapeutics offering "precision" (or "personalized") medicine. As with many areas of medicine, research benefiting our most vulnerable patients, namely neonates and children, has lagged that of adult populations. Unfortunately, newborns and children bear a large share of the sepsis burden especially regarding mortality. 1,2 In this issue of Pediatric Research , Dr. Wang and colleagues have published their manuscript titled "Elevated Total Bile Acid Levels as an Independent Predictor of Mortality in Pediatric Sepsis". 3 In this retrospective analysis, the authors managed to perform a case-control study with 702 septic children (538 survivors and 164 non-survivors) admitted to a single pediatric intensive care unit (PICU) over a 5-year period. Importantly, the authors included an additional 269 non-infected controls that certainly strengthens the study. The authors conclude that serum total bile acids (TBA) appear to be an effective independent biomarker for predicting mortality in children with sepsis. Using a clinical model that identified TBA elevations greater than 17.9 μmol/L was an independent predictor of sepsis mortality with an AUC > 0.842, 54.9% sensitivity, and 96% specificity. Compared to control patients and sepsis survivors, the authors observed greater fluctuations and higher TBA values during hospitalization and at the time of death in the non-survivor cohort. Importantly, we believe that this study provides value by addressing two of the aforementioned challenges of pediatric sepsis – namely defining pediatric sepsis and evaluation for possible biomarkers. Wang et al. utilize the newly developed Phoenix-4 criteria to identify their septic cohort and investigate total bile acid levels as a potential biomarker. Defining sepsis across the age spectrum has been a longstanding challenge. Without clear cut age-specific definitions, treatment of sepsis in pediatric populations has relied heavily on a balance of clinical gestalt and available adult evidence. While numerous biomarkers have been investigated in pediatric sepsis, many lack the desired sensitivity and specificity or have not been widely validated in clinical use.

Serum proteome-wide identified ATP citrate lyase as a novel informative diagnostic and prognostic biomarker in pediatric sepsis: A pilot study

Comparison of the Diagnostic Efficacy of SAA1, HBP, CRP，PCT and Cytokine Profiles for Predicting Infection in Pediatric Febrile Patients

Apolipoprotein A-V Is a Novel Diagnostic and Prognostic Predictor in Pediatric Patients with Sepsis: A Prospective Pilot Study in PICU

Alanine, a potential amino acid biomarker of pediatric sepsis: a pilot study in PICU

Serum Neutrophil Gelatinase-Associated Lipocalin: A Diagnostic Marker in Pediatric Sepsis

The novel biomarkers for assessing clinical benefits of continuous renal replacement therapy in pediatric sepsis: a pilot study

Serum metabolite profiling reveals metabolic characteristics of sepsis patients using LC/MS-based metabolic profiles: a cross-sectional study

Examining bile acids in pediatric sepsis – a step in the right direction

Discrimination of serum metabolomics profiles in infants with sepsis, based on liquid chromatography-mass spectrometer

A Three-Protein Panel to Support the Diagnosis of Sepsis in Children

Renin and angiotensin (1–7) offer predictive value in pediatric sepsis: findings from prospective observational cohorts

Early Diagnostic Biomarkers of Sepsis for Patients with Acute-on-Chronic Liver Failure: A Multicenter Study

ATP-citrate lyase controls endothelial gluco-lipogenic metabolism and vascular inflammation in sepsis-associated organ injury

Diagnostic Accuracy of Plasma Ghrelin Concentrations in Pediatric Sepsis-Associated Acute Respiratory Distress Syndrome: A Single-Center Cohort Study

Prognostic Value of High-Sensitivity C-Reactive Protein, Procalcitonin and Pancreatic Stone Protein in Pediatric Sepsis

Promising results of a clinical feasibility study: CIRBP as a potential biomarker in pediatric cardiac surgery

Serum cystatin C, kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, klotho and fibroblast growth factor-23 in the early prediction of acute kidney injury associated with sepsis in a Chinese emergency cohort study

Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis

AST-to-Platelet Ratio Index as Potential Early-Warning Biomarker for Sepsis-Associated Liver Injury in Children: A Database Study.

Changes in serum adiponectin levels in children with severe sepsis and its clinical significance

The value of lymphocyte-to-C-reactive protein ratio for predicting clinical outcomes in patients with sepsis in intensive care unit: a retrospective single-center study